Similar articles for PMID: 28953106

Year	Number of Results
1994	1
1995	3
1996	2
1997	2
1998	3
1999	2
2000	5
2001	2
2002	6
2003	7
2004	7
2005	5
2006	3
2007	4
2008	7
2009	4
2010	3
2012	2
2013	2
2014	3
2015	2
2016	2
2017	8
2018	5
2019	2
2021	3
2023	1
2024	0

1

Levosimendan in Advanced Heart Failure: Where Do We Stand?

Abbate A, Van Tassell BW. Abbate A, et al. J Cardiovasc Pharmacol. 2018 Mar;71(3):127-128. doi: 10.1097/FJC.0000000000000539. J Cardiovasc Pharmacol. 2018. PMID: 28953106 Free PMC article. No abstract available.

2

Levosimendan in patients with decompensated heart failure.

Rosa EM, Osório AP, Scopel L. Rosa EM, et al. Arq Bras Cardiol. 2008 Aug;91(2):119. doi: 10.1590/s0066-782x2008001400010. Arq Bras Cardiol. 2008. PMID: 18709265 Free article. English, Portuguese. No abstract available.

3

Repetitive levosimendan in outpatients affected by advanced heart failure: the need for a uniform approach.

Maiello C, Cacciatore F, Amarelli C, Palmieri V, Golino P. Maiello C, et al. J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):149. doi: 10.2459/JCM.0000000000001090. J Cardiovasc Med (Hagerstown). 2021. PMID: 32858638 No abstract available.

4

Can we believe in levosimendan?

Follath F. Follath F. Arq Bras Cardiol. 2008 Mar;90(3):146-7. doi: 10.1590/s0066-782x2008000300001. Arq Bras Cardiol. 2008. PMID: 18392391 Free article. English, Portuguese. No abstract available.

5

Levosimendan use in several scenarios of acute heart failure.

Tavares M, Andrade AC, Mebazaa A. Tavares M, et al. Arq Bras Cardiol. 2008 Mar;90(3):211-5. doi: 10.1590/s0066-782x2008000300012. Arq Bras Cardiol. 2008. PMID: 18392402 Free article. Review. English, Portuguese.

6

Repeated infusion of levosimendan in outpatients with advanced heart failure: to cure sometimes, to relieve often, and to comfort always.

Masarone D, Pacileo G. Masarone D, et al. J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):150. doi: 10.2459/JCM.0000000000001100. J Cardiovasc Med (Hagerstown). 2021. PMID: 32858644 No abstract available.

7

Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.

Biala A, Martonen E, Kaheinen P, Levijoki J, Finckenberg P, Merasto S, Louhelainen M, Muller DN, Luft FC, Mervaala E. Biala A, et al. Hypertens Res. 2010 Oct;33(10):1004-11. doi: 10.1038/hr.2010.123. Epub 2010 Sep 2. Hypertens Res. 2010. PMID: 20811386

8

Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W. Slawsky MT, et al. Circulation. 2000 Oct 31;102(18):2222-7. doi: 10.1161/01.cir.102.18.2222. Circulation. 2000. PMID: 11056096 Clinical Trial.

9

Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.

Kivikko M, Lehtonen L. Kivikko M, et al. Curr Pharm Des. 2005;11(4):435-55. doi: 10.2174/1381612053382043. Curr Pharm Des. 2005. PMID: 15725064 Review.

10

Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.

Louhelainen M, Vahtola E, Forsten H, Merasto S, Kytö V, Finckenberg P, Leskinen H, Kaheinen P, Tikkanen I, Levijoki J, Mervaala E. Louhelainen M, et al. J Hypertens. 2009 Oct;27(10):2094-107. doi: 10.1097/HJH.0b013e32832f0ce4. J Hypertens. 2009. PMID: 19730126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year